Hydromadinone acetate
Hydromadinone acetate (developmental code name NSC-33170), also known as chloroacetoxyprogesterone (CAP), as well as 6α-chloro-17α-acetoxyprogesterone or 6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is a steroidal progestin of the 17α-hydroxyprogesterone group that was never marketed.[1][2] It is the C17α acetate ester of hydromadinone, which, similarly, was never marketed.[1]
 | |
| Clinical data | |
|---|---|
| Other names | NSC-33170; Chloroacetoxyprogesterone; CAP; 6α-Chloro-17α-acetoxyprogesterone; 6α-Chloro-17α-acetoxypregn-4-ene-3,20-dione |
| Drug class | Progestogen; Progestogen ester |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ECHA InfoCard | 100.124.835  |
| Chemical and physical data | |
| Formula | C23H31ClO4 |
| Molar mass | 406.95 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 255–. ISBN 978-1-4757-2085-3.
- Martin Negwer; Hans-Georg Scharnow (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 3723. ISBN 978-3-527-30247-5.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.